Full Research Article
The Effect of Epigenetic Modifiers on the Production of Lipase-inhibiting Secondary Metabolites in Aspergillus fischeri VO1R, An Endophyte from Viola odorata
- Email asqarquvatovxabb@mail.ru

The Effect of Epigenetic Modifiers on the Production of Lipase-inhibiting Secondary Metabolites in Aspergillus fischeri VO1R, An Endophyte from Viola odorata
Submitted23-03-2026|
Accepted11-07-2026|
First Online 29-07-2026|
Background: This study investigated the impact of epigenetic modifiers (5-azacytidine, nicotinamide and quercetin) on the growth, secondary metabolite production and lipase-inhibitory activity of the endophytic fungus Aspergillus fischeri VO1R, isolated from the roots of Viola odorata. The study’s findings demonstrate that the addition of modifiers reduced overall biomass and metabolite production, while maintaining the initial, relatively high level of lipase-inhibitory activity. A pronounced effect on biomass production was observed with the use of 5-azacytidine. These results shed light on the potential of epigenetic regulators to activate silent genes and stimulate the synthesis of more effective inhibitors, thereby enhancing our understanding of natural enzyme inhibitors.
Methods: During the study the dishes were incubated for 7 days at 28°C. Cultivation was performed in liquid Czapek-Dox medium supplemented with 5-azacytidine, nicotinamide and quercetin at a final concentration of 100 µL on a shaker at 180 rpm and 28°C for seven days. The culture biomass was separated by centrifugation at 6,000 rpm, weighed and stored at -4°C until use.
Result: Thus, the specific activity of metabolites, or the proportion of inhibitory metabolites, increased in the presence of azacitidine, quercetin and nicotinamide at different times of cultivation. For example, with the addition of 5-azacytidine on the seventh day of cultivation, the inhibitory activity of the extract was 94.6% given that the amount of dry extract of metabolites was 14.9 mg. In comparison, in the control, the inhibitory activity was 91.5% and the amount of extract was almost three times greater (42 mg). Thus, a significant increase in the specific inhibitory activity of the compounds was produced in the presence of the epigenetic modifier.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.